BriaCell Therapeutics Statistics
Total Valuation
BCTX has a market cap or net worth of $37.08 million. The enterprise value is $30.83 million.
Market Cap | 37.08M |
Enterprise Value | 30.83M |
Important Dates
The next estimated earnings date is Wednesday, June 12, 2024, after market close.
Earnings Date | Jun 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
BCTX has 15.98 million shares outstanding. The number of shares has increased by 2.99% in one year.
Shares Outstanding | 15.98M |
Shares Change (YoY) | +2.99% |
Shares Change (QoQ) | -4.16% |
Owned by Insiders (%) | 12.27% |
Owned by Institutions (%) | 13.79% |
Float | 11.64M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.99
Current Ratio | 2.99 |
Quick Ratio | 1.60 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 3.76 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -57.70% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$790,404 |
Employee Count | 16 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.21% in the last 52 weeks. The beta is 1.75, so BCTX's price volatility has been higher than the market average.
Beta (1Y) | 1.75 |
52-Week Price Change | -68.21% |
50-Day Moving Average | 2.91 |
200-Day Moving Average | 4.77 |
Relative Strength Index (RSI) | 41.23 |
Average Volume (30 Days) | 85,479 |
Short Selling Information
The latest short interest is 677,909, so 4.24% of the outstanding shares have been sold short.
Short Interest | 677,909 |
Short Previous Month | 733,317 |
Short % of Shares Out | 4.24% |
Short % of Float | 5.82% |
Short Ratio (days to cover) | 6.14 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -31.72M |
Pretax Income | -12.65M |
Net Income | -12.65M |
EBITDA | -17.21M |
EBIT | -17.23M |
Earnings Per Share (EPS) | -$1.68 |
Balance Sheet
The company has $6.24 million in cash and no debt, giving a net cash position of $6.24 million or $0.39 per share.
Cash & Cash Equivalents | 6.24M |
Total Debt | n/a |
Net Cash | 6.24M |
Net Cash Per Share | $0.39 |
Equity / Book Value | -8.07M |
Book Value Per Share | -0.51 |
Working Capital | 7.82M |
Cash Flow
Operating Cash Flow | -31.26M |
Capital Expenditures | n/a |
Free Cash Flow | -31.26M |
FCF Per Share | -$1.96 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
BCTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.99% |
Shareholder Yield | -2.99% |
Earnings Yield | -34.11% |
FCF Yield | -84.30% |
Analyst Forecast
The average price target for BCTX is $18.00, which is 675.86% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $18.00 |
Price Target Difference | 675.86% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 2, 2020. It was a reverse split with a ratio of 1:300.
Last Split Date | Jan 2, 2020 |
Split Type | Reverse |
Split Ratio | 1:300 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |